AEGiS-SC: Fighting AIDS: Africans must also commit to the war against AIDS San Francisco ChronicleImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to San Francisco Chronicle main menu
DonateNow
Print this article

Fighting AIDS: Africans must also commit to the war against AIDS

San Francisco Chronicle - Sunday, May 18, 2003
Richard Tren*


Africans are pleased to see that the U.S. government is showing its concern for the victims of AIDS on our continent with a $15 billion assistance package. Unfortunately, the same cannot be said of our own governments. And sadly, no amount of money or free drugs from the United States will help us until our own governments commit to the fight against AIDS.

HIV infection continues to rise in Africa while mortality from HIV- related illnesses increases. Few African governments can be proud of their response to the epidemic. The South African government continues to dither in its AIDS policy, and for the first time since the end of apartheid, activist groups have used civil disobedience campaigns to provoke action. In Zimbabwe, President Mugabe irrationally focused on blaming homosexuals for AIDS rather than crafting an effective plan to confront the crisis.

Yet there are some countries that have faced this catastrophe admirably. Uganda's President Museveni showed bold political leadership and courage years ago by taking quick, effective action. His government promoted AIDS prevention and education, but also ensured that people had access to treatment, thereby reducing infection rates by 50 percent since 1992.

Botswana has the highest HIV infection rates in Africa and the world, with approximately 36 percent of the adult population infected. President Mogae's plan -- working with the Bill and Melinda Gates Foundation, the pharmaceutical giant Merck and other institutions such as Harvard University toward improving the health infrastructure, reducing infection and making sure that more people have access to essential drugs -- has borne positive results.

Other African leaders should learn that political will to fight AIDS goes far beyond wearing a red ribbon and making heartfelt speeches. African governments must end widespread corruption, so that drugs that are either donated or purchased cheaply go to those who require them and are not sold to the private sector. They must also ensure that drugs are not sold back into the European or American market, reducing the willingness of drug companies to make price reductions.

Political will also means that governments change their spending patterns. It is outrageous that the South African government claims it cannot afford to treat people with HIV/AIDS, but spends billions on armaments and a new jet for President Mbeki.

Antiretroviral drugs are needed in Africa; pilot projects have shown that in many instances they can be taken correctly and the regimens can be adhered to. But such efforts require enormous investment in health infrastructure and training. Moreover, no treatment program can be effective if it does not reduce the stigmatization of HIV-positive people, a situation that prevents many from seeking help.

While President Bush's announcement of a $15 billion plan to fight AIDS is welcome, it will not be easy to reach the stated goal of 2 million people on antiretroviral treatment without improving infrastructure. The few African success stories show that one of the best ways of doing this is to work with the research drug companies that have developed the medicines.

Nigeria recently experimented with generic antiretroviral drugs from India and this proved disastrous, with fewer than 10 percent of those intended to get drugs actually receiving them. Generic suppliers rarely provide the necessary pharmacological backup and advice that pharmaceutical companies offer in addition to drugs.

Despite the international unpopularity of the research pharmaceutical sector, it often does more for health care in Africa than most governments. Major research drug companies have donated billions in charitable donations and continue to research medicines for diseases like malaria. Humanitarian assistance is important, but continued research into new drugs is most critical. Governments can help by protecting these companies -- investments through strong intellectual property rights.

In the long term however, Africa must increase economic growth to ensure wealth creation in poor countries. Developed countries can help by reducing trade barriers. African leaders must also reduce corruption, protect property rights, promote rule of law and remove the economic barriers they have created (such as high taxes on health imports).

Africans are ill, unable to receive medical treatment and short of food because most African governments have kept people poor, frustrated trade and interfered with markets. By increasing economic freedom and enabling the private sector to thrive, Africa will be able to create the wealth that can build health infrastructure. Bush's billions of dollars are crucially important, but Africans won't triumph over AIDS or poverty until their leaders make a true commitment their people.

* Richard Tren is director of Africa Fighting Malaria based in Johannesburg.


030518
SC030517


Copyright © 2003 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com.   http://www.sfgate.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .